Akt2 relaxes podocytes in chronic kidney disease
Author:
- 7 October 2013
- journal article
- editorial
- Published by Springer Nature in Nature Medicine
- Vol. 19 (10) , 1212-1213
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- AKT2 is essential to maintain podocyte viability and function during chronic kidney diseaseNature Medicine, 2013
- Akt2 regulates Rac1 activity in the insulin-dependent signaling pathway leading to GLUT4 translocation to the plasma membrane in skeletal muscle cellsCellular Signalling, 2013
- Podocyte Biology and Pathogenesis of Kidney DiseaseAnnual Review of Medicine, 2013
- Role of Rac1–mineralocorticoid-receptor signalling in renal and cardiac diseaseNature Reviews Nephrology, 2013
- Podocyte GTPases regulate kidney filter dynamicsKidney International, 2012
- mTOR Signaling in Growth Control and DiseaseCell, 2012
- mTOR inhibitor–associated proteinuria in kidney transplant recipientsTransplantation Reviews, 2012
- CD2AP in mouse and human podocytes controls a proteolytic program that regulates cytoskeletal structure and cellular survivalJournal of Clinical Investigation, 2011
- Role of mTOR in podocyte function and diabetic nephropathy in humans and miceJournal of Clinical Investigation, 2011
- Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKBMolecular Cell, 2006